Skip to content

Clinical trials

Phase 2/3 Retinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Phase 2/3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20192
20202
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Completed2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laboratoires Thea2
ProQR Therapeutics2
AbbVie1
Jaeb Center for Health Research1
Kodiak Sciences Inc1
Leiden University Medical Center1
Meyer Children's Hospital IRCCS1
Retinagenix Holdings1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases10
Eye Diseases6
Vision Disorders5
Eye Abnormalities4
Eye Diseases, Hereditary3
Macular Degeneration3
Retinal Degeneration3
Blindness2
Leber Congenital Amaurosis2
Neurologic Manifestations2

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.